SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-022775
Filing Date
2023-08-09
Accepted
2023-08-09 16:02:30
Documents
41
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20230630_10q.htm   iXBRL 10-Q 484410
2 EXHIBIT 31.1 ex_554829.htm EX-31.1 11911
3 EXHIBIT 31.2 ex_554830.htm EX-31.2 11892
4 EXHIBIT 32.1 ex_554831.htm EX-32.1 3568
5 EXHIBIT 32.2 ex_554832.htm EX-32.2 3813
  Complete submission text file 0001437749-23-022775.txt   2187283

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA govx-20230630.xsd EX-101.SCH 22576
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20230630_def.xml EX-101.DEF 139025
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20230630_lab.xml EX-101.LAB 136860
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20230630_pre.xml EX-101.PRE 153333
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20230630_cal.xml EX-101.CAL 24624
35 EXTRACTED XBRL INSTANCE DOCUMENT govx20230630_10q_htm.xml XML 192738
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 231155002
SIC: 2834 Pharmaceutical Preparations